Assessment of Differential Pharmacodynamic Effects Using Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration

PURPOSE. To use novel OCT parameters in assessing the differential pharmacodynamic effects of bevacizumab (Avastin; Genentech, South San Francisco, CA), pegaptanib (Macugen; OSI Pharmaceuticals, New York, NY), and verteporfin photodynamic therapy (PDT; Novartis, Basel, Switzerland) in a recently com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keane, Pearse A., Heussen, Florian M., Ouyang, Yanling, Mokwa, Nils, Walsh, Alexander C., Tufail, Adnan, Sadda, Srinivas R., Patel, Praveen J.
Formato: Artigo
Idioma:Inglês
Publicado em: Association for Research in Vision and Ophthalmology, Inc. 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3339900/
https://ncbi.nlm.nih.gov/pubmed/22281826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.11-8130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados